These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4930211)

  • 1. Treatment of myelomatosis--M.R.C. trial.
    Galton DA
    Br Med J; 1971 May; 2(5757):323-4. PubMed ID: 4930211
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide vs melphalan in treatment of plasma cell myeloma.
    Rivers SL; Patno ME
    JAMA; 1969 Feb; 207(7):1328-34. PubMed ID: 4179565
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunochemical classes of myelomatosis. Including data from a therapeutic trial conducted by a Medical Research Council working party.
    Hobbs JR
    Br J Haematol; 1969 Jun; 16(6):599-606. PubMed ID: 4184690
    [No Abstract]   [Full Text] [Related]  

  • 4. Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.
    Br J Haematol; 1973 Jan; 24(1):123-39. PubMed ID: 4805842
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease].
    Bontoux D; Chenbit D; Delbarre F
    Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple myeloma without initial paraproteins.
    Kim I; Harley JB; Weksler B
    Am J Med Sci; 1972 Oct; 264(4):267-75. PubMed ID: 4630526
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of multiple myeloma.
    Malpas JS
    Br Med J; 1969 Apr; 2(5650):163-5. PubMed ID: 5778941
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients.
    Carbone PP; Kellerhouse LE; Gehan EA
    Am J Med; 1967 Jun; 42(6):937-48. PubMed ID: 6027163
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic hemodialysis in myelomatosis.
    Leech SH; Polesky HF; Shapiro FL
    Ann Intern Med; 1972 Aug; 77(2):239-42. PubMed ID: 4641657
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myeloma : symptoms, diagnosis, treatment].
    Piguet H; Borg JY; Monconduit M; Bizet M
    Rev Prat; 1979 Jan; 29(3):333-6, 339-44, 347-8. PubMed ID: 419356
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term survival in myelomatosis. A report to the MRC working party on leukaemia in adults.
    Buckman R; Cuzick J; Galton DA
    Br J Haematol; 1982 Dec; 52(4):589-99. PubMed ID: 6958312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring myelomatosis.
    Hobbs JR
    Arch Intern Med; 1975 Jan; 135(1):125-30. PubMed ID: 1111461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelomatosis: comparison of melphalan and cyclophosphamide therapy.
    Br Med J; 1971 Mar; 1(5750):640-1. PubMed ID: 4926948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma--development of alternative malignancy following successful chemotherapy.
    Holt JM; Robb-Smith AH; Callender ST; Spriggs AI
    Br J Haematol; 1972 May; 22(5):633. PubMed ID: 4503794
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth rates and responses to treatment in human myelomatosis.
    Hobbs JR
    Br J Haematol; 1969 Jun; 16(6):607-17. PubMed ID: 4184691
    [No Abstract]   [Full Text] [Related]  

  • 16. Melphalan therapy for plasma cell myeloma.
    Alexanian R; Bergsagel DE; Migliore PJ; Vaughn WK; Howe CD
    Blood; 1968 Jan; 31(1):1-10. PubMed ID: 5638562
    [No Abstract]   [Full Text] [Related]  

  • 17. [Visceral calcinosis induced by intravenous phosphate perfusions in myelomatous hypercalcemia].
    Deshayes P; Levillain D; Cauvin M; Forthomme J
    Sem Hop; 1969 Feb; 45(7):444-9. PubMed ID: 4307115
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients.
    Matzner Y; Benbassat J; Polliack A
    Isr J Med Sci; 1977 Aug; 13(8):797-807. PubMed ID: 408296
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognosis of myelomatosis on treatment with prednisone and cytostatics.
    Hansen OP; Jessen B; Videbaek A
    Scand J Haematol; 1973; 10(4):282-90. PubMed ID: 4764610
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.
    Bergsagel DE; Cowan DH; Hasselback R
    Can Med Assoc J; 1972 Nov; 107(9):851-5. PubMed ID: 4653931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.